High correlation between clinical responses to 1st line AML patients treated with cytarabine and idarubicin and their pharmacological profiles in patient samples measured by exvitech.
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Fecha de publicación
2014Título de revista
Haematologica
Tipo de contenido
Publicación de congreso
![](/xmlui/themes/Mirage2//images/final_lines.png)